It is very nice to visit Lambda facility and thanks to warm welcome provided by all the teams. I can easily say one of the best CRO I ever visited. People here are wonderful and doing great job

Reputed Client of Israel

Awesome hospitality & fantastic office. All the best!

Reputed Client of Japan

Excellent hospitality and cooperation received throughout the audit. People are knowledgeable and extremely transparent. Looking for long time relation

Reputed Client of Asia

Facility is too good to conduct the BABE studies and adherence to protocol and quality assurance in conducting studies are meeting sponsor expectations and requirements.

Reputed Client of India

Facility is good, people r trained well and know the subject on which they r working. All the best.

Reputed Client of USA

Highly innovative and advanced research centre that possess bright future for the development of the country.

Reputed International Government Body

It is one of the best facility in India for BA/BE

Reputed Regulatory Authority

Lambda is a very professional CRO. All the staff here are experienced and very knowledgeable. I'm grateful for their accommodations and hospitality. The future, if we want to carry out BE study, we will ask Lambda help again.

Reputed Client of Europe

It was a really pleasant meeting with the PV department, and I am looking forward to the next visit.

Reputed Client of Europe

Amazing and best CRO I ever seen

Reputed Client of China

Company News

Company News

Home / Company News

Lambda Therapeutic Research Ltd, organised a Symposium on "Innovation in Clinical Trials"

17 Aug 2016

Lambda Therapeutic Research successfully conducted a symposium on "Innovation in Clinical Trials"; on the 15th & 16th of March, 2013 at Ahmedabad. Around 50 delegates from different Pharmaceutical & Biotechnology organisations across India participated in this two day symposium, which was inaugurated by Dr. H.G. Koshiya - Commissioner, Food & Drug Control Administration, Government of Gujarat and Dr. Ramkishan (ADC) - CDSCO, Zonal Office, Ahmedabad. Lambda's initiative to organise such a knowledge sharing event in Ahmedabad and committed efforts of their Managing Director, Mrs. Bindi Chudgar as well as Team Lambda were acknowledged and appreciated by all delegates.

Renowned and eminent scientists from the Drug Development & Clinical Research arena assembled to discuss and explore new thoughts and learning to understand the ever changing dynamics of the Industry. The Current Regulatory Environment and the new regulations were discussed with the Commissioner, Food & Drug Control Administration-Gujarat and Assistant Drug Controller, CDSCO, Zonal Office- Ahmedabad, who also attended the symposium. Mr. Sanjeev Kaul (MD, Chrys Capital Advisors) and Mr. Sudarshan Jain (MD, Abbott Healthcare) were among the eminent speakers invited for the symposium.

Topics like the latest challenges in Global Clinical Trials, Market Outlook for the Indian Clinical Trial Industry, Investment trends in Drug Discovery and Development, Current trends in Data Management in Clinical Trials etc. and other topics straddling all the latest trends and updates in the industry were well received. The objective of conducting this symposium was met and knowledge in the arenas of Innovation in drug development and clinical research was shared in the group.

All the participants felt the need of conducting such symposiums in future and Lambda is determined to continue with this precedent established by holding such events on more regular basis in the future.